Prostatis Group’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Hold
1,189
0.08% 128
2026
Q1
$324K Sell
1,189
-403
-25% -$115K 0.08% 134
2025
Q4
$458K Sell
1,592
-270
-15% -$75.4K 0.11% 108
2025
Q3
$483K Buy
1,862
+6
+0.3% +$1.5K 0.12% 97
2025
Q2
$461K Buy
1,856
+129
+7% +$31.9K 0.13% 100
2025
Q1
$457K Buy
1,727
+24
+1% +$6.39K 0.14% 96
2024
Q4
$432K Sell
1,703
-365
-18% -$98.3K 0.13% 110
2024
Q3
$584K Buy
2,068
+232
+13% +$64.4K 0.19% 86
2024
Q2
$488K Sell
1,836
-373
-17% -$97.8K 0.17% 97
2024
Q1
$598K Buy
2,209
+220
+11% +$57.8K 0.23% 86
2023
Q4
$499K Buy
1,989
+596
+43% +$141K 0.21% 84
2023
Q3
$327K Buy
1,393
+124
+10% +$30.2K 0.16% 78
2023
Q2
$311K Sell
1,269
-37
-3% -$9K 0.14% 88
2023
Q1
$312K Buy
1,306
+1
+0.1% +$241 0.16% 79
2022
Q4
$324K Buy
1,305
+1
+0.1% +$242 0.2% 75
2022
Q3
$292K Buy
+1,304
New +$311K 0.34% 44

Other funds holding VHT

Prostatis Group's VHT Position: Q2 2026 in Review

Prostatis Group held its Vanguard Health Care ETF (VHT) position steady in Q2 2026 at 1,189 shares worth $356K. The position accounts for 0.08% of the portfolio, ranked #128.

Prostatis Group first reported a position in VHT in Q3 2022 and has held it in 16 quarters since. The position peaked at $598K in Q1 2024. 1,116 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Prostatis Group held 1,189 shares of Vanguard Health Care ETF worth $356K as of Q2 2026.
  • Prostatis Group left its Vanguard Health Care ETF share count unchanged in Q2 2026.
  • Vanguard Health Care ETF made up 0.08% of Prostatis Group's portfolio in Q2 2026, its #128 holding.
  • Prostatis Group first reported a position in Vanguard Health Care ETF in Q3 2022 and has held it in 16 quarters since.
  • Prostatis Group's Vanguard Health Care ETF position peaked at $598K in Q1 2024.
  • 1,116 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.